No abstract

Although there were differences in treatment success between DM subjects and non-diabetic individuals, they were not significant for the most measured parameters. The results of this study did not absolutely support the assumption that the level of glycemic control significantly affected the periodontal therapy outcome in diabetics.

The periodontal therapy bears good results in HIV-positive patients. Additional administration of OCT contributes to the significant decline in the PBI and DS values and eliminates atypical microorganisms within 1 month post-treatment. However, more favourable results were not noted in the OCT group at the 3-month assessment.

Key advantages of Poly(methyl methacrylate)—PMMA for denture application are related to aesthetics and biocompatibility, while its main deficiency is related to mechanical properties. To address this issue, SiO2 nanoparticle reinforcement was proposed, containing 0 to 5% nanosilica, to form nanocomposite materials. Flexural strengths and elastic moduli were determined and correlated to nominal nanoparticle content and zeta potential of the liquid phase nanoparticle solutions. Another issue is the biocompatibility, which was determined in terms of cytotoxicity, using L929 and MRC5 cell lines. The addition of nanoparticle was proved to be beneficial for increasing flexural strength and modulus, causing a significant increase in both strength and moduli. On the other hand, the formation of agglomerates was noted, particularly at higher nanoparticle loadings, affecting mechanical properties. The addition of nanosilica had an adverse effect on the cytotoxicity, increasing it above the level present in unmodified specimens. Cytotoxic potential was on the acceptable level for specimens with up to 2% nanosilica. Consequently, nanosilica proved to be an effective and biocompatible means of increasing the resistance of dental materials.

Chronic periodontitis is a common complication in diabetes. The aim of this study was to evaluate some clinical and microbiological parameters in controlled and uncontrolled type 2 diabetes mellitus (type 2 DM) patients compared to non-diabetic (NDM) individuals, as well as to assess the effect of non-surgical periodontal therapy on these parameters. The study was performed in 61 type 2 DM patients with periodontitis (group 1A: 29 patients having achieved good metabolic control, HbA1c <7%; group 1B: 32 patients with poor metabolic control, HbA1c ≥7%), and 31 NDM individuals suffering from periodontitis. Periodontal indices (plaque index, PI; gingival index, GI; probing pocket depth, PPD; and clinical attachment level, CAL) were measured and subgingival plaque samples were analyzed using polymerase chain reaction prior to treatment initiation and 3 months post-treatment. The results recorded on the majority of measured parameters indicated that differences in treatment success achieved in the three treatment groups were not statistically significant (∆PI p=0.646; ∆GI p=0.303; and ∆CAL p=0.233). Likewise, comparison of the effectiveness in microorganism reduction revealed no significant differences between DM groups and NDM patients. Therefore, study results supported the hypothesis that periodontal therapy outcome was unaffected by the level of glycemic control in patients with diabetes.